| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |